Course: Optimizing Bispecific Antibody Treatment for Non-Hodgkin Lymphoma: Current Best Practices for Mitigating and Managing Cytokine Release Syndrome
CME Credits: 1.00
Released: 2025-09-22
The goal of this educational activity is to equip and empower oncology pharmacists, nurse practitioners (NPs), and nurses with the knowledge, competence, and confidence they need to ensure the safe and effective use of bispecific antibodies (BsAbs) for patients with B-cell non-Hodgkin lymphoma, with a particular emphasis on best practice monitoring, mitigation, and collaborative management of BsAb-associated cytokine release syndrome within integrated clinical workflows and logistical frameworks.
		  
			            Upon completion of this activity, participants should be better able to:           
View Full Course